ACUTE LYMPHOBLASTIC LEUKAEMIA
Clinical trials for ACUTE LYMPHOBLASTIC LEUKAEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKAEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes aim at genetic weakness in tough blood cancers
Disease control Recruiting nowThis early-phase study is testing an experimental oral drug called AZD3632 in about 84 people with advanced blood cancers (acute leukemias or myelodysplastic syndromes) that have certain genetic changes. The main goals are to check the drug's safety and find the right dose, while…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKAEMIA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for tough blood cancers? early trial launches
Disease control Recruiting nowThis early-stage study is testing a new biologic drug called CC312 in 44 adults with certain blood cancers (like lymphoma or leukemia) that have returned or not responded to standard treatments. The main goals are to check safety and find the right dose. Participants receive CC31…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKAEMIA
Phase: PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC